Main > ONCOLOGY (**) > Lung>NSCLC>MET>PD-L1+>> *** > Treatment > USA. B. PD-1 MAb ***
USA. B. PD-1 MAb ***'s subsections
(*) CA; USA; Approved
(*) CN Approval Date: 2018. 06.15.
(*) EU Approval Date: 2015. 07.20.
(*) EU Approval PR Web-Site
>Not Has Abnormal "EFFR"/"ALK" Gene
>Tried Pt CT & Not Works & Tumor>
Company
Generic Name: NivoluMAb
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2018. 10.16.
RTM
RTM Web-Site
USA. B. PD-1 MAb ***'s products
This section has no products